Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06515015Not ApplicableRecruiting

Evaluation of the Feasibility, Safety, and Efficacy of Single-use Endobronchial Silicon Spigots for the Treatment of Refractory Pneumothorax

Role: lead

NCT05799664Not ApplicableRecruiting

Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD

Role: lead

NCT04619472Not ApplicableCompleted

Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors

Role: lead

NCT06052098Not ApplicableRecruiting

Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer

Role: lead

NCT04139408Not ApplicableCompleted

Safety and Effectiveness of Disposable Pulmonary Surgical Markers in the Localization of Pulmonary Nodules

Role: lead

All 5 trials loaded